SEDAT KOÇAK
(Necmettin Erbakan Üniversitesi Meram Tıp Fakültesi, Acil Tıp Anabilim Dalı, Konya, Türkiye)
Atıf HARMANKAYA
(Eskişehir Yunus Emre Devlet Hastanesi, Acil Tıp Kliniği, Eskişehir, Türkiye)
Esma ERDEMİR
(Beyhekim Devlet Hastanesi, Acil Tıp Kliniği, Konya, Türkiye)
ZERRİN DEFNE DÜNDAR
(Necmettin Erbakan Üniversitesi Meram Tıp Fakültesi, Acil Tıp Anabilim Dalı, Konya, Türkiye)
Recep KEŞLİ
(Afyon Kocatepe Üniversitesi, Tıp Fakültesi, Mikrobiyoloji Anabilim Dalı, Afyon, Türkiye)
Hayrudin ALİBASİC
(Özel Büyükşehir Hastanesi, Kardiyoloji Kliniği, Konya, Türkiye)
Yıl: 2016Cilt: 15Sayı: 4ISSN: 2149-5807 / 2149-6048Sayfa Aralığı: 157 - 162İngilizce

123 4
Association of Severity of Coronary Lesion with Markers of Acute Infection and Inflammation in Patients with Acute Coronary Syndrome
Fen > Tıp > Acil Tıp
DergiAraştırma MakalesiErişime Açık
  • Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-26. [CrossRef]
  • Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of cor- onary artery disease and acute coronary syndromes. N Engl J Med 1992; 326: 242-50. [CrossRef]
  • Kornowski R, Hong MK, Tio FO, Brambell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial in- jury to neointimal hyperplasia. J Am Coll Cardiol 1998; 31: 224-30. [CrossRef]
  • Gotsman I, Stabholz A, Planer D, Pugatsch T, Lapidus L, Novikov Y, et al. Serum cytokine tumor necrosis factor-alpha and interleukin-6 associat- ed with the severity of coronary artery disease: indicators of an active inflammatory burden? Isr Med Assoc J 2008; 10: 494-8.
  • Potekhina AV, Sokolov VO, Pylaeva EA, Provatorov SI, Masenko VP, Bosykh EG et al. Changes of content of regulatory lymphocytes and concentra- tion of soluble interleukine-2 receptor in blood of patients with ischemi- che heart disease after coronary artery angioplasty with implantation of stents with rapamyc covering. Kardiologiia 2011; 51: 47-53.
  • Wang TJ, Nam BH, Wilson PW, Wolf PA, Levy D, Polak JF, et al. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham heart study. Arterioscler Thromb Vasc Biol 2002; 22: 1662-7. [CrossRef]
  • Ridker PM, Hennekenes CH, Buring JE, Rifai N. C-reactive protein and oth- er markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43. [CrossRef]
  • Nicolle LE. Chlamydia pneumoniae and atherosclerosis: the end? Can J Infect Dis Med Microbiol 2005; 16: 267-8. [CrossRef]
  • Zibaeenezhad MJ, Amanat A, Alborzi A, Obudi A. Relation of Chlamydia pneumoniae infection to documented coronary artery disease in Shiraz, Southern Iran. Angiology 2005; 56: 43-8. [CrossRef]
  • Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, et al. Associ- ation of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005; 45: 1219-22. [CrossRef]
  • Zhu J, Quyyumi AA, Norman JE, Csako G, Waclawiw MA, Shearer GM, et al. Effects of total pathogen burden on coronary artery disease risk and C-reactive protein levels. Am J Cardiol 2000; 85: 140-6. [CrossRef]
  • Gensini GG. A more meaningful scoring system for determining the se- verity of coronary heart disease. Am J Cardiol 1983; 51: 606. [CrossRef]
  • Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regula- tory pathways. Physiol Rev 2006; 86: 515-81. [CrossRef]
  • Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-43. [CrossRef]
  • Hoffman M, Blum A, Baruch R, Kaplan E, Benjamin M. Leukocytes and coronary heart disease. Atherosclerosis 2004; 172: 1-6. [CrossRef]
  • Sukhija R, Fahdi I, Garza L, Fink L, Scott M, Aude W, et al. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol 2007; 99: 879-84. [CrossRef]
  • Heinisch RH, Zanetti CR, Comin F, Fernandes JL, Ramires JA, Serrano CV Jr. Serial changes in plasma levels of cytokines in patients with coronary artery disease. Vasc Health Risk Manag 2005; 1: 245-50.
  • Sakamoto A, Ishizaka N, Saito K, Imai Y, Morita H, Koike K, et al. Serum lev- els of IgG4 and soluble interleukin-2 receptor in patients with coronary artery disease. Clin Chim Acta 2012; 413: 577-81. [CrossRef]
  • Nijm J, Wikby A, Tompa A, Olsson AG, Jonasson L. Circulating levels of proin- flammatory cytokines and neutrophil-platelet aggregates in patients with coronary artery disease. Am J Cardiol 2005; 95: 452-6. [CrossRef]
  • Hu WS, Hwang JM. Association of Serum Cytokines, Human Growth Hor- mone, Insulin-Like Growth Factor (IGF)-I, IGF-II and IGF-Binding Protein (IGFBP)-3 with Coronary Artery Disease. Chin J Physiol 2012; 55: 267-73.
  • de Werra I, Jaccard C, Corradin SB, Chioléro R, Yersin B, Gallati H, et al. Cy- tokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and pro- calcitonin concentrations: Comparisons in patients with septic shock, car- diogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25: 607-13. [CrossRef]
  • Meisner M, Adina H, Schmidt J. Correlation of procalcitonin and C-reactive pro- tein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 2006; 10: R1. [CrossRef]
  • Wanner GA, Keel M, Steckholzer U, Beier W, Stocker R, Ertel W. Relation- ship between procalcitonin plasma levels and severity of injury, sepsis, organ failure, and mortality in injured patients. Crit Care Med 2000; 28: 950-7. [CrossRef]
  • Erren M, Reinecke H, Junker R, Fobker M, Schulte H, Schurek JO, et al. Sys- temic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 1999; 19: 2355-63. [CrossRef]
  • Wunder C, Eichelbrönner O, Roewer N. Are IL-6, IL-10 and PCT plas- ma concentrations reliable for outcome prediction in severe sepsis? A comparison with APACHE III and SAPS II. Inflamm Res 2004; 53: 158-63. [CrossRef]
  • Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cyto- kines in vitro. J Lab Clin Med 1999; 134: 49-55 [CrossRef]
  • Reilly MP, Rohatgi A, McMahon K, Wolfe ML, Pinto SC, Rhodes T, et al. Plasma cytokines, metabolic syndrome, and atherosclerosis in humans. J Investig Med 2007; 55: 26-35. [CrossRef]
  • Sinning CR, Sinning JM, Schulz A, Schnabel RB, Lubos E, Wild PS, et al. Association of serum procalcitonin with cardiovascular prognosis in cor- onary artery disease. Circ J 2011; 75: 1184-91. [CrossRef]
  • Padmavati S, Gupta U, Agarwal HK. Chronic infections & coronary artery disease with special reference to chalmydia pneumoniae. Indian J Med Res 2012; 135: 228-32.
  • Mundkur LA, Rao VS, Hebbagudi S, Shanker J, Shivanandan H, Nagaraj RK and et al. Pathogen burden, cytomegalovirus infection and inflammato- ry markers in the risk of premature coronary artery disease in individuals of Indian origin. Exp Clin Cardiol 2012; 17: 63-8.
  • Nikitskaya EA, Grivel JC, Maryukhnich EV, Lebedeva AM, Ivanova OI, Sav- vinova PP, et al. Cytomegalovirus in plasma of acute coronary syndrome patients. Acta Naturae 2016; 8: 102-7.
  • Tabata N, Sueta D, Akasaka T, Arima Y, Sakamoto K, Yamamoto E, et al. Helicobacter pylori seropositivity in patients with Interleukin-1 polymor- phisms is significantly associated with ST-Segment Elevation Myocardial Infarction. PLoS One 2016; 11: e0166240. [CrossRef]

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.